Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

belatacept

Known as: CD152 antigen, CTLA4-Ig 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND In previous analyses of BENEFIT, a phase 3 study, belatacept-based immunosuppression, as compared with cyclosporine… Expand
Highly Cited
2011
Highly Cited
2011
BACKGROUND AND OBJECTIVES Prolonged use of calcineurin inhibitors (CNIs) in kidney transplant recipients is associated with renal… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2010
Highly Cited
2010
Belatacept, a costimulation blocker, may preserve renal function and improve long‐term outcomes versus calcineurin inhibitors in… Expand
Highly Cited
2010
Highly Cited
2010
Recipients of extended criteria donor (ECD) kidneys are at increased risk for graft dysfunction/loss, and may benefit from… Expand
Highly Cited
2010
Highly Cited
2010
Belatacept is a first-in-class co-stimulation blocker in development for primary maintenance immunosuppression. A Phase II study… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Highly Cited
2005
Highly Cited
2005
Current success in organ transplantation is dependent upon the use of calcineurin‐inhibitor‐based immunosuppressive regimens… Expand
Highly Cited
2005
Highly Cited
2005
BACKGROUND Renal transplantation is the standard of care for patients with end-stage renal disease. Although maintenance… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2005
Highly Cited
2005
 
Highly Cited
1997
Highly Cited
1997
Selective inhibition of T cell costimulation using the B7-specific fusion protein CTLA4-Ig has been shown to induce long-term… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1994
Highly Cited
1994
The rejection of the transplanted allograft is dependent on T cell activation, which requires T cell receptor engagement by… Expand